Valiant Organics Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹304 Cr +93.6% YoYSee revenue, profit and what management said. You are viewing Q1 FY27.
VO

Valiant Organics Ltd

Q1 FY27Chemicals & Petrochemicals

Valiant Organics Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹232Cr
+13.7% YoY
+6.4% QoQ
Net profit
₹29Cr
+262.5% YoY
+81.3% QoQ
Margin
18%
+6 pp YoY
+6 pp QoQ

Based on Valiant Organics Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹411
Market cap₹1.2K Cr
P/E23.7

The short version

Revenue from Operations for Q1-FY27: INR 2,315 million - Year-on-year (YoY) growth in Revenue: 13.3% increase from INR 2,044 million in Q1-FY26 (Page 13, 12) - Total Revenue reported as INR 2,342 million for Q1-FY27 with 14% YoY growth (Page 10) - Sales volumes by chemistry for Q1-FY27 (metric tons): - Chlorination: approx. Q1-FY27 EBITDA: INR 416 million - EBITDA Margin: 17.97% - Year-on-Year EBITDA Growth: 67.7% (from INR 248 million in Q1-FY26) - EBITDA Margin Increase: +584 basis points YoY

From Valiant Organics Ltd's Q1 FY27 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Revenue from Operations for Q1-FY27: INR 2,315 million
  • Year-on-year (YoY) growth in Revenue: 13.3% increase from INR 2,044 million in Q1-FY26 (Page 13, 12)
  • Total Revenue reported as INR 2,342 million for Q1-FY27 with 14% YoY growth (Page 10)
  • Sales volumes by chemistry for Q1-FY27 (metric tons):
  • Chlorination: approx. 440 MT
  • Hydrogenation: approx. 478 MT
  • Ammonolysis: approx. 513 MT

2 more points from Valiant Organics Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Valiant Organics Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

It provides: - Manufacturing footprint details with existing capacities for various chemistries and locations but no planned expansions. - Operational and financial highlights focused on current production and performance. Thus, based solely on the presentation content, no capex or capacity expansion initiatives are described.

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Valiant Organics Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Valiant Organics Ltd said on order book & pipeline — free account, 30 seconds.

Valiant Organics Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Valiant Organics Ltd Q1 FY27 results — key figures

Valiant Organics Ltd Q1 FY27 reported results vs Q1 FY26, ₹ crore
₹ CrQ1 FY27Q1 FY26YoYQ4 FY26QoQ
Revenue232204+13.7%218+6.4%
Operating profit (EBITDA)4225+68%26+61.5%
Operating margin18%12%+6 pp12%+6 pp
Profit before tax3711+236.4%18+105.6%
Net profit (PAT)298+262.5%16+81.3%
EPS (₹)10.362.93+253.6%5.61+84.7%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹304 Cr, net profit ₹17 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Alufluoride (Q1 FY27)

    Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr

  • POCL Enterprises (Q1 FY27)

    466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto

  • Devson Catalyst (Q1 FY27)

    FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee

  • Ambani Orgochem (Q1 FY27)

    Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Valiant Organics Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Valiant Organics Ltd Q1 FY27 results?

Revenue from Operations for Q1-FY27: INR 2,315 million - Year-on-year (YoY) growth in Revenue: 13.3% increase from INR 2,044 million in Q1-FY26 (Page 13, 12) - Total Revenue reported as INR 2,342 million for Q1-FY27 with 14% YoY growth (Page 10) - Sales volumes by chemistry for Q1-FY27 (metric tons): - Chlorination: approx. Q1-FY27 EBITDA: INR 416 million - EBITDA Margin: 17.97% - Year-on-Year EBITDA Growth: 67.7% (from INR 248 million in Q1-FY26) - EBITDA Margin Increase: +584 basis points YoY

What is Valiant Organics Ltd share price analysis?

Valiant Organics Ltd currently shows a neutral. The stock trades at a P/E of 23.7 with a market cap of ₹1,196 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Valiant Organics Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.